MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 48 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,113 | -67.0% | 162,410 | 0.0% | 0.01% | -66.7% |
Q2 2023 | $64,071 | -16.1% | 162,410 | 0.0% | 0.03% | -21.1% |
Q1 2023 | $76,333 | -6.0% | 162,410 | 0.0% | 0.04% | -9.5% |
Q4 2022 | $81,205 | -21.2% | 162,410 | 0.0% | 0.04% | -28.8% |
Q3 2022 | $103,000 | -8.8% | 162,410 | +14.0% | 0.06% | -4.8% |
Q2 2022 | $113,000 | -1.7% | 142,410 | 0.0% | 0.06% | +12.7% |
Q1 2022 | $115,000 | -29.4% | 142,410 | -11.6% | 0.06% | -23.6% |
Q4 2021 | $163,000 | -24.2% | 161,160 | -2.4% | 0.07% | -26.5% |
Q3 2021 | $215,000 | +45.3% | 165,160 | -13.6% | 0.10% | +60.7% |
Q2 2021 | $148,000 | -31.5% | 191,160 | +20.5% | 0.06% | -41.9% |
Q4 2020 | $216,000 | +66.2% | 158,660 | -6.2% | 0.10% | +31.2% |
Q3 2020 | $130,000 | +16.1% | 169,160 | +16.7% | 0.08% | +1.3% |
Q2 2020 | $112,000 | +86.7% | 145,000 | +45.0% | 0.08% | +43.6% |
Q1 2020 | $60,000 | -73.6% | 100,000 | 0.0% | 0.06% | -67.8% |
Q4 2019 | $227,000 | – | 100,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COURAGE CAPITAL MANAGEMENT LLC | 1,000,000 | $804,000 | 0.77% |
Sargent Investment Group, LLC | 3,643,979 | $2,931,000 | 0.74% |
Arkadios Wealth Advisors | 1,399,000 | $1,125,000 | 0.15% |
Kingsbury Capital Investment Advisors LLC | 119,949 | $96,000 | 0.11% |
JTC Employer Solutions Trustee Ltd | 775,000 | $632,000 | 0.07% |
Platform Technology Partners | 142,410 | $115,000 | 0.06% |
Main Street Financial Solutions, LLC | 400,826 | $322,000 | 0.05% |
National Wealth Management Group, LLC | 32,100 | $25,821 | 0.02% |
STALEY CAPITAL ADVISERS INC | 600,000 | $483,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 753,391 | $606,000 | 0.01% |